Keyphrases
Age of Onset
6%
Aging
8%
AIDS/HIV
6%
Alzheimer's Dementia
13%
Alzheimer's Disease
88%
Alzheimer's Disease Biomarkers
5%
Alzheimer's Disease Model
6%
Alzheimer's Disease Pathology
11%
Amyloid Deposition
5%
Amyloid Plaques
5%
Amyloid Precursor Protein
5%
Amyotrophic Lateral Sclerosis
12%
Aneurysmal Subarachnoid Hemorrhage (aSAH)
5%
APOE4
8%
Apolipoprotein E
14%
Astrocytes
11%
Autism
6%
Autism Spectrum Disorder
8%
Autosomal Dominant Alzheimer's Disease
8%
Brain Development
5%
Brain Injury
8%
Brain Regions
8%
Central Nervous System
15%
Cerebral Blood Flow
8%
Cerebrospinal Fluid
29%
Cerebrospinal Fluid Biomarkers
8%
Clinical Dementia Rating
8%
Clinical Features
6%
Clinical Outcomes
6%
Clinical Trials
16%
Cochlear Implant
5%
Cochlear Implantation
5%
Cognitive Decline
7%
Cognitive Impairment
12%
Cognitively Normal
8%
Confidence Interval
14%
Cortex
5%
COVID-19
6%
Dementia
18%
Diffusion Tensor Imaging
7%
Disease Progression
7%
Duchenne muscular Dystrophy
10%
Dystonia
5%
Early Alzheimer's Disease
7%
Epilepsy
12%
Experimental Autoimmune Encephalomyelitis
6%
Frontotemporal Dementia
7%
Frontotemporal Lobar Degeneration
5%
Functional Connectivity
9%
Functional Magnetic Resonance Imaging
11%
Genome-wide Association Study
5%
Glioblastoma
5%
Glioma
5%
High Risk
5%
Hippocampus
6%
HIV-associated Neurocognitive Disorders
5%
Human Brain
6%
Huntington's Disease
5%
Hydrocephalus
5%
Intracerebral Hemorrhage
5%
Ischemic Stroke
7%
Knock-in Mouse Model
5%
Late-onset Alzheimer's Disease
5%
Magnetic Resonance Imaging
17%
Meta-analysis
5%
Microglia
9%
Mild Cognitive Impairment
8%
Mouse Model
11%
Multiple Sclerosis
27%
Neonate
5%
Neurodegeneration
12%
Neurodegenerative Diseases
9%
Neurofibromatosis Type 1 (NF-1)
26%
Neurofibromatosis Type I
17%
Neuroimaging
9%
Neuroinflammation
5%
Neuropathology
7%
Odds Ratio
9%
Older Adults
15%
Optic Pathway Glioma
5%
Parkinson's Disease
24%
Pathophysiology
5%
Pediatric
8%
People Living with HIV (PLHIV)
5%
Placebo
7%
Plaque
5%
Positron Emission Tomography
12%
Quality of Life
5%
Resting-state Functional Connectivity (rs-FC)
6%
Resting-state Functional Magnetic Resonance Imaging (rs-fMRI)
6%
Risk Factors
8%
Seizure
17%
Sporadic Alzheimer's Disease
13%
Subarachnoid Hemorrhage
10%
Traumatic Brain Injury
5%
Tuberous Sclerosis Complex
5%
Tumor
12%
United States
8%
White Matter
8%
Neuroscience
Alzheimer's Disease
100%
Amyloid Precursor Protein
5%
Amyloid Protein
44%
Amyotrophic Lateral Sclerosis
9%
Apolipoprotein E
11%
Astrocyte
13%
Autism
6%
Axon
7%
Behavior (Neuroscience)
15%
Blood Plasma
14%
Brain Development
5%
Brain Ischemia
15%
Brain Network
6%
Central Nervous System
12%
Cerebral Hemorrhage
8%
Cerebrovascular Accident
21%
Clinical Dementia Rating
7%
Cognitive Disorders
14%
Diffusion Tensor Imaging
7%
Dystonia
6%
Electroencephalogram
5%
Fluorine-18
6%
Frontotemporal Dementia
5%
Functional Connectivity
12%
Functional Magnetic Resonance Imaging
17%
Gene Expression
5%
Gray Matter
6%
Hippocampus
8%
Human Immunodeficiency Virus
19%
Hydrocephalus
8%
In Vitro
9%
In Vivo
18%
Intracranial Tumor
5%
Ischemia
5%
Magnetic Resonance Imaging
21%
Magnetic Resonance Imaging
18%
Metabolic Pathway
8%
Microglia
8%
Mild Cognitive Impairment
8%
Multiple Sclerosis
23%
Muscle Disorder
5%
Muscular Dystrophy
5%
Nervous System Disorder
5%
Neurodegeneration
12%
Neurodegenerative Disorder
9%
Neurofibromatosis Type 1
14%
Neuropathy
7%
Neurotrauma
7%
Parkinson's Disease
22%
Pervasive Developmental Disorder
5%
Placebo
5%
Positron Emission Tomography
15%
Positron Emission Tomography
9%
Receptor
10%
Resting-State Functional Connectivity
6%
Stereotypic Movement Disorder
5%
Subarachnoid Hemorrhage
9%
Traumatic Brain Injury
7%
Tuberous Sclerosis
5%
Medicine and Dentistry
Alzheimer's Disease
46%
Amyloid Protein
18%
Apoplexy
18%
Autosomal Dominant Inheritance
6%
Biological Marker
17%
Brain Injury
5%
Brain Ischemia
10%
Central Nervous System
7%
Cerebral Hemorrhage
7%
Cerebrospinal Fluid
15%
Clinical Trial
13%
Clinician
6%
Cochlear Implant
5%
Cochlear Implantation
5%
Cognitive Defect
6%
COVID-19
6%
Diagnosis
9%
Disease
5%
Diseases
24%
Duchenne Muscular Dystrophy
6%
Epileptic Seizure
17%
Ganglioglioma
11%
Human Immunodeficiency Virus
11%
Magnetic Resonance Imaging
18%
Malignant Neoplasm
5%
Microglia
5%
Multiple Sclerosis
10%
Neoplasm
19%
Neurofibromatosis Type I
18%
Odds Ratio
6%
Parkinson's Disease
7%
Pediatrics
19%
Placebo
6%
Positron Emission Tomography
9%
Prevalence
5%
Subarachnoid Hemorrhage
7%
Surgery
8%
Tau
12%